Fatigue that sleep doesn’t fix. A mood that turns without warning. Nights that run hot, a body that seems to be keeping different weight in different places than it used to. It’s tempting to read that list and reach for a single word — hormones — and tempting, too, for an online quiz to hand it back to you as a diagnosis. The honest answer is quieter: those symptoms could be several things at once, and only a clinician reading labs against your history can tell which.
Midlife is when the endocrine system, so steady for so long, starts to renegotiate. For women it arrives as a defined transition. For men it’s slower and less dramatic, more a slope than a cliff. Both are ordinary parts of a life, not failures of one. And both are surrounded by a lot of confident marketing that a careful clinician would slow down.
What actually changes
Start with the part that has a clear arc. In women, the years leading up to menopause are called perimenopause — a transition in which the ovaries wind down and the hormones that governed the monthly cycle stop keeping a schedule. Estradiol (the main form of estrogen) and progesterone swing and, over time, fall; the pituitary hormone FSH tends to rise as the body works harder to prompt ovaries that are becoming less responsive. Cycles grow irregular. This is often where symptoms begin — hot flashes, disrupted sleep, mood shifts, changes in memory or libido — and it can run for years.
Menopause itself is not a phase but a milestone, defined looking backward: the point reached after twelve consecutive months without a period. The years that follow are postmenopause. Naming the stage matters, because the same symptom can mean different things depending on where in the arc it appears.
Men have no equivalent milestone. What some men experience instead is a gradual, years-long decline in testosterone, sometimes called andropause or, more precisely, late-onset hypogonadism. It is slow enough that many men never notice it, and for those who do, it’s associated with symptoms like flagging energy, low mood, reduced libido, or changes in strength and body composition. The catch is that every one of those symptoms has a long list of other causes — which is exactly why age alone can’t confirm it.
Why a symptom quiz isn’t enough
Here is the uncomfortable overlap at the center of this whole topic. Poor sleep produces fatigue, brain fog, low mood, and low libido. So does chronic stress. So can an underactive thyroid, iron deficiency, depression, and a dozen other ordinary things. And so can the hormonal transitions above. Line the symptom lists up side by side and they are nearly indistinguishable.
A symptom quiz can only see the symptoms. Feed it a tired, foggy, low-libido midlife adult and it will confidently point at hormones — because that’s the answer it was built to give — while a thyroid problem or a sleep debt sits unexamined underneath. That’s not a small error. It can send someone toward a treatment they don’t need and away from the one they do.
The clinician-led version works the other way around. It treats the symptoms as a question, not an answer, and goes looking for what’s actually driving them: a focused history, the right labs, and the patience to rule things out before ruling anything in.
How it’s measured
This is where labs earn their place — not as a verdict a number hands down on its own, but as one input a clinician reads in context, against your history, your symptoms, and the rest of your health. The point of a panel isn’t to produce a diagnosis by itself; it’s to give a trained reader something more reliable than a checklist.
History & symptom pattern The starting point
Where you are in the arc, what changed and when, cycle patterns, sleep, stress, medications, and family history. Not a quiz score — a conversation that shapes which tests are worth ordering and how to read them.
The hormone panel, read in context Labs, not a checklist
In women, hormones like FSH and estradiol are interpreted alongside the clinical picture and the staging framework clinicians use to describe the menopause transition (often referred to as STRAW+10). In men, total and free testosterone with SHBG are the usual starting labs. These are measurements a clinician interprets, not thresholds you self-diagnose from.
Confirm and rule out Before ruling anything in
Testosterone naturally varies through the day, so a single low reading isn’t a conclusion — the usual approach is a repeat morning draw to confirm. Alongside it, a clinician looks at what else could explain the symptoms, such as thyroid function, so hormones aren’t blamed for something else’s work.
A lab value is a data point, not a diagnosis. What makes it useful is a clinician reading it together with everything else — which is the opposite of what a quiz does.
How it’s managed
The honest version is less dramatic than the ads, and it starts in the same place for almost everyone: the fundamentals. They aren’t a consolation prize before the “real” treatment — they’re the foundation any responsible plan is built on, and for many people they do a great deal of the work.
- The fundamentals, first. Protected sleep, strength training, enough protein, and a real handle on stress are associated with steadier energy, mood, and body composition through these transitions. For many people they change the picture meaningfully on their own.
- Symptom-specific care. Some symptoms have targeted, well-established approaches that a clinician can discuss with you individually — treated on their own terms rather than swept into a single hormonal explanation.
- Hormone therapy, where clinically indicated and only after a proper evaluation. For some people — HRT (hormone therapy) for women, TRT (testosterone therapy) for men — this enters the conversation. It is individualized, its risks and benefits weighed by a clinician against your history and goals, and monitored over time. Testosterone is a controlled substance; this is prescription medicine, not a supplement. It is a conversation with a care team, never a checkout button — and this page is not that conversation.
Notice the order. Hormone therapy is neither the villain nor the shortcut it’s sometimes made out to be online. For the right person, after a proper evaluation, it can be part of a considered plan. For the wrong one, it’s a treatment aimed at the wrong problem. The only way to know which you are is the unglamorous one: measure, understand, and decide with a clinician.
The Peak You approach
That’s the loop Peak You is built on: measure → understand → clinician-guided plan → re-test. Your history and labs are read together, in plain language rather than a wall of reference ranges, so the question — is this the transition, or sleep, or thyroid, or several at once? — gets a real answer instead of a quiz’s guess. Where a plan is warranted, it starts with the fundamentals and, only where a clinician judges it appropriate after a proper evaluation, considers more. Then you re-test, because a single reading is a snapshot and what matters is where the next one lands.
The clinician-led version, grounded in your labs
There’s no quick quiz here on purpose. Peak You pairs a real clinical care team with a coach that reads your history and longitudinal labs in context — so what’s driving your symptoms gets identified, not assumed. Any decision about hormone therapy is made with a clinician, after a proper evaluation.
See how Peak You reads your hormones in context →Frequently asked
Is perimenopause the same as menopause?
No. Perimenopause is the transition — the years when cycles and hormones like estradiol and progesterone become erratic and symptoms often begin. Menopause is a single point looking backward: the milestone reached after twelve consecutive months without a period, with the years after called postmenopause. Which stage you’re in is something a clinician reads from your history and, where useful, labs — not from a checklist alone.
Do men really go through andropause?
Men don’t have an abrupt equivalent of menopause. What some men experience is a gradual, years-long decline in testosterone, sometimes labelled andropause or late-onset hypogonadism. For some it’s associated with symptoms like low energy, mood changes, or reduced libido; for many it’s quiet. Because those symptoms overlap heavily with sleep, stress, and other conditions, it’s confirmed with labs and history, not assumed from age.
Can you treat this without hormones?
For many people, the fundamentals do meaningful work: sleep, strength training, adequate protein, and managing stress are associated with steadier energy, mood, and body composition through these transitions. Whether anything beyond the fundamentals is appropriate is an individual decision made with a clinician after a proper evaluation.
Are hormone therapies safe?
There’s no single yes-or-no answer, because the risks and benefits depend on the person, their history, their goals, and the specific therapy. Hormone therapy for women and testosterone therapy for men are clinician-governed treatments — testosterone therapy involves a controlled substance — considered only after a proper evaluation, with the trade-offs weighed individually and monitored over time. It’s a conversation with a care team, never a checkout button, and this page isn’t that conversation.
Sources & medical review
⚠ Compliance-pending. This explainer is written from well-established, broadly accepted clinical understanding of the midlife hormonal transitions. Because this is among the highest-sensitivity topics in the library — hormone therapy and testosterone therapy are prescription treatments, and testosterone is a controlled substance — every specific claim, definition, and framing must be verified against primary sources and cited before publication, and the page must carry a named clinician reviewer and review date (E-E-A-T). In particular, the “twelve consecutive months” definition of menopause, the description of FSH/estradiol and STRAW+10 staging, the total/free testosterone and SHBG measurement approach, the repeat-morning-draw confirmation, and every statement about HRT/TRT indications, risks, and benefits require source verification and clinician sign-off. Specific numeric thresholds are deliberately omitted pending review.
Sources to attach in review: menopause and perimenopause definitions and staging (STRAW+10) guidance; FSH/estradiol interpretation literature; menopause hormone therapy (HRT) benefit–risk guideline statements; late-onset hypogonadism / andropause diagnostic criteria; total and free testosterone plus SHBG measurement and repeat-draw guidance; testosterone therapy (TRT) indication, monitoring, and controlled-substance regulatory guidance; symptom-overlap evidence for thyroid, sleep, and stress; lifestyle-intervention effects (strength training, protein, sleep, stress) on midlife hormonal symptoms.
This content is for general education and is not medical advice, diagnosis, or treatment. It does not establish a patient–provider relationship. Ranges and rules of thumb are population signals, not individual verdicts. Hormone therapy and testosterone therapy are prescription treatments that carry individual risks and benefits and are appropriate only after a proper evaluation; nothing here should be read as a recommendation to seek, start, or obtain them. Talk with a qualified clinician about your own history and numbers before acting on anything you read here.